Twitter’s Market Valuation Suggests Wall St. Sees Huge

New Post Public Reply Private Reply Replies (1) Message Board
equijohn

Twitter’s Market Valuation Suggests Wall St. Sees Huge Growth Potential

Under Dick Costolo, who became Twitter’s chief executive in 2010, Twitter developed its first formats for advertising.Eduardo Munoz/ReutersUnder Dick Costolo, who became Twitter’s chief executive in 2010, Twitter developed its first formats for advertising.

Twitter is a young company generating large losses as it competes in a highly uncertain sector of the economy.

And that is exactly why investors clamored for a piece of its initial public offering, which closed on Wednesday evening.

Twitter’s shares were priced at $26, giving the company an overall value of $18.1 billion, including stock that the company is likely to issue to employees. That makes Twitter worth more than many storied American corporations, like Alcoa and Harley-Davidson. At that valuation, each of Twitter’s 230 million users around the world is worth $78. Going by such numbers, the public offering has been a tremendous success for the company, which raised $1.8 billion from the offering, a hefty war chest.

Article Tools

  • FACEBOOK
  • SAVE
  • TWITTER
  • E-MAIL
  • GOOGLE+
  • PRINT
  • SHARE

Related Links

All this is impressive for a company that has racked up more than $300 million of losses in the last three years — and may not show real profits until 2015.

But investors are betting that Twitter is virtually destined to become wildly profitable as advertisers pay it increasing amounts of money to reach consumers who use the service.

“The possibilities and opportunities afforded by the platform are limitless,” Dick Costolo, Twitter’s chief executive, said in a company presentation to promote the offering. Still, if recent history has anything to teach, the euphoria is unlikely to last.

The fast-changing world of technology can be cruelly unpredictable. It tripped up companies like Groupon and, for a while, Facebook, Twitter’s much larger rival for advertising dollars. If Twitter also slips up, its shares could tumble fast, too.

“That’s always the peril of high-growth stocks,” said Lawrence Levine, a partner and a specialist in financial valuation at McGladrey, an accounting firm. “So much of the valuation is embedded in the expected growth rate.”

Wall Street’s bullish case for Twitter is seductively simple.

The company has established itself as a major hub for social media activity, alongside Facebook and Google. Now, as advertisers devote more of their spending to Internet campaigns, analysts expect that Twitter will almost inevitably rake in a sizable share of that spending. Its revenue should — in theory — soar. The company, according to analysts, could post revenue of $1.9 billion in 2015, three times what the company is expected to make this year.

Yet Twitter’s stock price, even before its first day of trading, may already reflect most of that growth.

Shares of Twitter begin trading on the New York Stock Exchange on Thursday. If underwriters exercise an option to sell 10.5 million more shares to satisfy demand in the market — in what the industry refers to as an overallotment or “green shoe” — the company’s haul will rise to $2.1 billion, and its valuation will grow to about $18.3 billion. Twitter’s underwriters are expected to make use of the green shoe because of strong appetite from investors, according to people briefed on the matter.

The company could start trading with a market value of around 11 times its expected 2015 revenue, according to estimates from Sterne Agee. At that multiple, Twitter would already be more expensive than other social companies, like Facebook, Yelp and LinkedIn. The market is valuing those companies at a lower multiple of 8.5 times their expected 2015 revenue, according to Sterne Agee.

Twitter is not expected to be profitable under generally accepted accounting rules until 2015. Skeptics wonder whether this is because the company is struggling to find ways to serve advertisers.

To a certain extent, social media companies are black boxes, making them harder to value than companies with more visible, conventional businesses. A company like Twitter sits on an enormous number of user interactions, and it has to determine how to exploit those for advertisers. But it has offered few specifics on exactly how it will enable advertisers to place the right ad with the right users.

Twitter has released intriguing numbers that have excited investors. For instance, it says that, in the third quarter of this year, it took in $2.58 in advertising revenue for every 1,000 times that American users interacted with their Twitter accounts. In effect, the company is booking a quarter of a cent every time American users do something on their feeds, which suggests Twitter is sitting on a reliably lucrative business.

Outside the United States, where the company has 77 percent of its users, the figure is only 36 cents for every 1,000 interactions. Bullish analysts say the low figure shows that Twitter has room for growth.

But it is not clear how engaged the international users are compared with American ones. One way to track engagement is to look at how many daily active users Twitter has in each region. But unlike Facebook, Twitter has given only a daily active user figure for the entire company — around 100 million, which is less than half the monthly active users.

As Twitter’s public offering was closing on Wednesday, Mary Jo White, the chairwoman of the Securities and Exchange Commission, gave a speech that raised questions about the sort of numbers that appear in Twitter’s financial documents.

“Consider a company that correctly claims it has a hundred million users, and that the rate of user growth is expected to continue to grow at double-digit rates,” she said, while not mentioning Twitter. “What if the bulk of the growth in the number of users is in an area where the company has not yet figured out how to turn those users into paying customers?”

After months of foundering, Facebook found ways to substantially increase its advertising revenue, so far proving its doubters wrong. The temptation is to expect Twitter to do the same. But the problem is that the company may already be priced for perfection.

“One day Twitter will make money,” said Anup Srivastava, an assistant professor of accounting at Northwestern University’s Kellogg School of Management. “But it’s not clear why anyone should pay this much for it today.”

Michael J. de la Merced contributed reporting.

EJstocks.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 22

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 20

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
HelloNation Brings 'Edvertising' to NC REALTORS® Event

Updated Category News Views 23

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 24

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 13

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 24

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
Merit Expands in New York with Bold Acquisition Move

Updated Category News Views 20

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Continue Reading
Vitamin Angels Drives Global Nutrition Advancements

Updated Category News Views 17

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 18

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 17

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading

Top 5 Most Recently Viewed Articles

Taitron's Strategic Shift: Nasdaq Delisting and Financial Update

Updated Category News Views 251

Overview of Taitron's Recent Developments Taitron Components Incorporated (NASDAQ: TAIT) recently made headlines by announcing its voluntary delisting from The Nasdaq Stock Market. The company's decision came as it recognized that the cost of maintaining its Nasdaq listing outweighed the benefits for its shareholders. Reasons Behind the Delisting The board concluded that...

Continue Reading
Merck's Two-Drug HIV Treatment Achieves Trial Success

Updated Category News Views 130

Merck's Groundbreaking Two-Drug Regimen for HIV Treatment Recently, Merck & Co Inc (NYSE: MRK) announced promising results from two important Phase 3 clinical trials. This involved their investigational two-drug regimen combining doravirine and islatravir (DOR/ISL) aimed at treating adults living with HIV-1 infection. Key Findings from the Trials The trials were designed...

Continue Reading
Immunic’s Patent Milestone for Vidofludimus Calcium in MS

Updated Category News Views 230

Immunic Achieves Patent Allowance for Vidofludimus Calcium Immunic, Inc. (Nasdaq: IMUX), a leading biotechnology firm, has recently marked a significant milestone by receiving a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application focused on the use of vidofludimus calcium, particularly in the treatment of progressive...

Continue Reading
Creatd, Inc. Advances with OTCQB Approval and Strong Equity

Updated Category News Views 148

Creatd, Inc. Takes a Significant Step with OTCQB Approval Creatd, Inc. (OTC: CRTD) has reached a significant milestone by being approved to trade on the OTCQB Venture Market. This remarkable achievement showcases the company's dedication and progress towards enhancing its market presence. Starting from a pivotal date, Creatd will now be traded on a more recognized...

Continue Reading
KROMATID Unveils Groundbreaking KROMASURE PinPoint Technology

Updated Category News Views 155

KROMATID Launches KROMASURE PinPoint for Enhanced Genomic Analysis With an aim to transform gene therapy development, KROMATID has unveiled its innovative KROMASURE PinPoint system. This next-generation platform revolutionizes transgene integration analysis by providing single-cell resolution that was previously unattainable. Researchers now have the ability to detect...

Continue Reading